GNLXNasdaqPharmaceutical PreparationsFiscal year ends December 31
GENELUX Corp
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$2.45+0.03 (+1.24%)
Close on Oct 19, 2026
- Market cap
- $110.15M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Genelux has not reported a dividend
No dividend per share appears in Genelux's annual filings since fiscal 2021.